Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients

Table 2

Lipid profile at baseline and at three months after starting anti-TNF therapy in psoriatic arthritis patients.

Variable	Baseline	Three months	𝑃 value
Total cholesterol (mg/dL)	157.1 ± 32.9	163.9 ± 33.8	0.30
HDL-c (mg/dL)	49.7 ± 15.4	45.1 ± 11.0	0.26
LDL-c (mg/dL)	91.7 ± 24.4	92.7 ± 18.9	0.39
VLDL-c (mg/dL)	25.3 ± 10.6	29.7 ± 12.5	0.016
Triglycerides (mg/dL)	126.1 ± 50.1	146.5 ± 61.4	0.024
Total cholesterol >200 mg/dL	1 (6)	0	1.0
HDL-c <40 mg/dL(male)/; <50 mg/dL(female)	5 (37)	5 (31)	1.0
LDL-c > 130 mg/dL	0	0	1.0
VLDL-c > 40 mg/dL	1 (6)	2 (12)	1.0
Triglycerides > 150 mg/dL	5 (31)	8 (50)	0.47

TNF: tumor necrosis factor, HDL-: high-density cholesterol, LDL: low-density cholesterol, and VLDL-c: very-low-density cholesterol.